Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 26, 2020 16:13 ET | Source: Genmab A/S

Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons

Company Announcement Copenhagen, Denmark; March 26, 2020 – In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the...
March 26, 2020 15:54 ET | Source: Genmab A/S

Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to the New Member of the Board of Directors and a New Member of Management, and Grant of Restricted Stock Units and Warrants to Employees and a New Member

Company Announcement Copenhagen, Denmark; March 26, 2020 – Following Genmab A/S’ (Nasdaq: GMAB) Annual General Meeting held on March 26, 2020, the Company’s Board of Directors met to constitute...
March 26, 2020 10:26 ET | Source: Genmab A/S

Passing of Genmab A/S’ Annual General Meeting

Company Announcement At Genmab A/S’ Annual General Meeting held today March 26, 2020, the Annual Report for 2019 was approvedDischarge was given to the Board of Directors and the Executive Management...
March 12, 2020 11:33 ET | Source: Genmab A/S

Genmab A/S Provides Update to Annual General Meeting

Media Release Copenhagen, Denmark, March 12, 2020 Genmab will hold Annual General Meeting (AGM) on March 26 as scheduledShareholders are asked to participate via a live webcast transmission and...
March 10, 2020 01:09 ET | Source: Genmab A/S

Genmab Announces Appointment of Anthony Mancini to Newly Created Position of Chief Operating Officer

Company Announcement Copenhagen, Denmark; March 10, 2020 – Genmab A/S (Nasdaq: GMAB) announced today that Anthony Mancini will join the company as Executive Vice President and Chief Operating...
February 27, 2020 04:03 ET | Source: Genmab A/S

Notice to Convene the Annual General Meeting of Genmab A/S

Company Announcement Genmab A/S to hold Annual General Meeting on March 26, 2020 Copenhagen, Denmark; February 27, 2020 – Genmab A/S (Nasdaq: GMAB) summons the Annual General Meeting on Thursday,...
February 26, 2020 12:30 ET | Source: Genmab A/S

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Company Announcement Copenhagen, Denmark; February 26, 2020 – In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses...
February 25, 2020 15:41 ET | Source: Genmab A/S

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Company Announcement Copenhagen, Denmark; February 25, 2020 – In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses...
February 25, 2020 15:28 ET | Source: Genmab A/S

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Company Announcement Copenhagen, Denmark; February 25, 2020 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 82,076 shares as a consequence of the exercise of employee warrants. The...
February 24, 2020 01:32 ET | Source: Genmab A/S

U.S. FDA Filing Acceptance and Priority Review for sBLA, Submitted by Novartis, for Ofatumumab in Relapsing Multiple Sclerosis

Media Release Copenhagen, Denmark, February 24, 2020 U.S. FDA has accepted, with priority review, the sBLA submitted by Novartis for subcutaneous ofatumumab in RMSNovartis anticipates potential...